CENTA

• Q3 FY2026 net sales were $882M, down 8% from $961M; organic net sales rose 2% to $862M.
• Gross margin expanded 130 bps to 35.9%; operating margin up 20 bps to 14.3%.
• Company raised FY2026 non-GAAP diluted EPS outlook to $2.85 or better from $2.70 or better.
• Agreed to acquire 80% of TRIXIE, a European pet supplies company, for up to €400M.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• Central Garden & Pet Company entered a Sale and Purchase Agreement to acquire approximately 80% of TRIXIE Heimtierbedarf GmbH & Co. KG, a German pet supplies and snacks company.
• TRIXIE's current shareholders Dirk Jessen and Volker Haak will retain ~20% of shares and have rights to require Central to buy them over at least three years, after which Central can require purchase.
• The acquisition is expected to close in the first half of Central's fiscal year ending September 25, 2027, subject to regulatory approval and customary conditions.
• TRIXIE will operate within Central's Pet segment; its leadership, including Dirk Jessen, Burkhard Friedrichsen, and Danny Bollerey, will remain in place.

8.01 Other Events · 9.01 Financial Statements and Exhibits

• GAAP diluted EPS was $1.28, up from $0.98 in Q2 FY2025.
• Gross margin expanded 30 basis points to 33.1%; operating margin rose to 12.6% from 11.2%.
• Company reaffirms fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better.
• Entered pet distribution partnership with Phillips, retaining 20% ownership stake.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• Kay M. Schwichtenberg, former EVP of Animal & Public Health, appointed to the board effective March 1, 2026.
• She will also join the Audit Committee effective March 1, 2026.
• Base salary increases approved for executives, effective January 1, 2026.
• Board approved a $100 million increase in stock repurchase authorization, bringing total to about $127 million.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 5.07 Submission of Matters to a Vote of Security Holders · 8.01 Other Events · 9.01 Financial Statements and Exhibits

• GAAP diluted EPS was $0.11, compared with $0.21 a year ago; non-GAAP diluted EPS was $0.21, flat year-over-year.
• Gross margin expanded 110 basis points to 30.9% (non-GAAP 30.8%), driven by improved productivity.
• Adjusted EBITDA was $50 million, down from $55 million; cash and cash equivalents totaled $721 million.
• Company reaffirmed fiscal 2026 non-GAAP diluted EPS guidance of $2.70 or better.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• Fiscal 2025 net sales were $3.1 billion, down 2% from $3.2 billion in fiscal 2024.
• GAAP EPS for fiscal 2025 was $2.55, up from $1.62; non-GAAP EPS was $2.73, up from $2.13.
• Fourth quarter net sales were $678 million, up 1% from $669 million; GAAP loss per share was $0.16 vs. $0.51.
• Fiscal 2026 non-GAAP EPS guidance is $2.70 or better, with capital spending projected at $50-$60 million.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• The facility includes an uncommitted accordion feature allowing up to an additional $400 million, subject to lender commitments.
• The credit facility matures on November 7, 2030, and no amounts were drawn at closing.
• Borrowings bear interest at SOFR (floor 0.00%) or Base Rate plus an applicable margin (1.00% for SOFR at closing; 0.00% for Base Rate at closing).
• The facility is secured by substantially all assets of the company and its guarantor subsidiaries, including pledges of 100% of domestic and 65% of foreign subsidiary equity.

1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 9.01 Financial Statements and Exhibits

• GAAP EPS increased 28% to $1.52; non-GAAP EPS increased 18% to $1.56, both versus the prior-year quarter.
• Operating income increased 17% to $135 million; non-GAAP operating income increased 9% to $139 million.
• Pet segment net sales fell 3% to $493 million; Garden segment net sales fell 4% to $468 million, with Garden operating income up 33%.
• Company reaffirms fiscal 2025 non-GAAP EPS guidance of approximately $2.60 and expects capital expenditures of $50-$60 million.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits